Literature DB >> 15841479

Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.

Katrin Sangkuhl1, Holger Römpler, Wibke Busch, Beate Karges, Torsten Schöneberg.   

Abstract

Mutations in the V2 vasopressin receptor (AVPR2) are the most frequent genetic cause of the inherited nephrogenic diabetes insipidus (NDI). About 50% of all missense mutations found in extracellular loops of AVPR2 introduce additional cysteine residues, e.g. R181C, G185C, and Y205C. To explain the loss of receptor function two mechanistic models were suggested: First, the introduction of an additional extracellular Cys residue disrupts the conserved disulfide bond connecting the first and the second extracellular loop. And second, the mutationally introduced Cys residue forms a second disulfide bond with a free Cys residue within the second exoloop. Herein, we took advantage of a new NDI-causing mutation Y205H which affects a codon frequently found to be mutated to Cys in NDI patients. In contrast to Y205C the two mechanisms described above cannot account for the loss of receptor function of Y205H. In-depth functional characterization of mutant AVPR2 showed that also for Y205C the lack of a Tyr residue at position 205 is responsible for the abolished receptor function rather than the formation of a disastrous second disulfide bond. The concerted experimental and phylogenetic analysis emphasizes that Y205 is a key residue in maintaining the structure of AVPR2 and other members of the vasopressin receptor family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841479     DOI: 10.1002/humu.9337

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Molecular and functional basis of phenotypic convergence in white lizards at White Sands.

Authors:  Erica Bree Rosenblum; Holger Römpler; Torsten Schöneberg; Hopi E Hoekstra
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

Review 2.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

3.  Nephrogenic diabetes insipidus : Old deletion, new effect. A case report of a family from Greece.

Authors:  D Tramma; S Kalamitsou
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

Review 4.  Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets.

Authors:  Paul A Insel; Chih-Min Tang; Ines Hahntow; Martin C Michel
Journal:  Biochim Biophys Acta       Date:  2006-10-05

5.  Structural and functional evolution of the trace amine-associated receptors TAAR3, TAAR4 and TAAR5 in primates.

Authors:  Claudia Stäubert; Iris Böselt; Jens Bohnekamp; Holger Römpler; Wolfgang Enard; Torsten Schöneberg
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

6.  A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.

Authors:  Marta Sanchez-Soto; Ravi Kumar Verma; Blair K A Willette; Elizabeth C Gonye; Annah M Moore; Amy E Moritz; Comfort A Boateng; Hideaki Yano; R Benjamin Free; Lei Shi; David R Sibley
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

7.  Structural and functional evolution of the P2Y(12)-like receptor group.

Authors:  Torsten Schöneberg; Thomas Hermsdorf; Eva Engemaier; Kathrin Engel; Ines Liebscher; Doreen Thor; Klaas Zierau; Holger Römpler; Angela Schulz
Journal:  Purinergic Signal       Date:  2007-09-06       Impact factor: 3.765

8.  A novel mutation in AVPR2 causing congenital nephrogenic diabetes insipidus with complete resistance to antidiuretic hormone.

Authors:  Alex Staffler; Marcus R Benz; Lutz T Weber; Andreas Holzinger
Journal:  NDT Plus       Date:  2008-12-09

9.  Involvement of the V2 vasopressin receptor in adaptation to limited water supply.

Authors:  Iris Böselt; Holger Römpler; Thomas Hermsdorf; Doreen Thor; Wibke Busch; Angela Schulz; Torsten Schöneberg
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.